Thus, it can be determined that AML cells can inhibit the expression of HLA-A by restricting the antigen presentation pathway, thereby avoiding anti-tumor immune responses after the activation of cytotoxic CD8+-T cells. The gene discussed is CD8A; the disease is acute myeloid leukemia.